Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests stronger membranes for better jawbone building

NCT ID NCT07525128

Disease control Sponsor: Saint-Joseph University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two different collagen membranes used in guided bone regeneration to widen the jawbone for dental implants. Ten healthy adults with narrow jawbones will receive a bone graft covered by either a standard cross-linked membrane or a stronger porcine peritoneum membrane. The goal is to see which membrane leads to more bone width gain, helping improve implant success.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * \- Patients aged 20 to 75 years. * Healthy individuals, either non-smokers or smokers consuming fewer than 10 cigarettes per day. * Full mouth bleeding score (FmBS) below 20%. * Full mouth plaque score (FmPS) below 15%. * Presence of a residual alveolar ridge with a bone width of less than 6 mm but sufficient bone height in the maxilla or mandible. * Tooth extraction must have been performed at least six weeks prior to surgery. * Adequate number of teeth to allow for the use of an occlusal stent or radiographic guide. Exclusion Criteria: * \- Presence of systemic illnesses. * Smoking more than 10 cigarettes per day. * Underwent radiotherapy in the head or neck region within the past 5 years. * Active periodontitis affecting the remaining teeth. * Pregnancy. * Use of medications that could impact bone turnover or mucosal healing, such as tetracycline in the last month, steroids within the past 6 months, bisphosphonates, therapeutic doses of fluorides, or vitamin D and its metabolites within the last 6 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bone augmentation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bone augmentation Guided bone regeneration Guided bone regeneration for lateral ridge augmentation and bone width improvement in implant dentistry

Contacts and locations

Locations

  • Saint Joseph University of Beirut , Campus of Medical Sciences

    Beirut, Beirut, 10001111, Lebanon

More trials for these conditions

Other studies related to the condition(s) this trial covers.